V
Vivek Yadala
Assistant Professor
faculty
COM | Internal Med Hem-Onc
4 h-index
20 pubs
102 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Vivek Yadala's research focuses on hematology and oncology, with a particular emphasis on the clinical outcomes and treatment strategies for various cancers. His work includes analyzing real-world data to understand the prognostic significance of factors like the neutrophil-lymphocyte ratio in lung cancer patients. He has also investigated the role of consolidative thoracic and prophylactic cranial radiation in extensive-stage small cell lung cancer within the context of chemo-immunotherapy. Yadala's publications also address immune-related adverse events, such as sarcoid-like reactions induced by immunotherapy, and rare hematological conditions like cyclic thrombocytopenia and severe immune thrombocytopenic purpura associated with COVID-19 vaccination. He has explored the value of imaging guidance in bone marrow biopsies and contributed to quality improvement studies in cancer diagnosis.
Metrics
- h-index: 4
- Publications: 20
- Citations: 102
Selected Publications
-
Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr (2025)
Collaboration Network
Top Collaborators
Jai Kumar Khatri
Marshall University (US)
3 shared publications
- BPI22-024: Assessing the Adherence to Standard of Care With Durvalumab and Overcoming Barriers in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Study
- Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era.
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Maria Tria Tirona
Marshall University (US)
3 shared publications
- BPI22-024: Assessing the Adherence to Standard of Care With Durvalumab and Overcoming Barriers in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Study
- Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era.
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Jennifer L. Dotson
Marshall University (US)
3 shared publications
- Cyclic Thrombocytopenia: A Case Report
- COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura
- Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era.
Mina Shenouda
Marshall University (US)
3 shared publications
- Bone Marrow Biopsy, Does CT Guidance Add Value?
- QIM23-144: A Race Against Time in Cancer Diagnosis: A QI Study
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Muhammad Jamil
3 shared publications
- Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era.
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Madhulika Urella
Edwards Comprehensive Cancer Center (US)
2 shared publications
- BPI22-024: Assessing the Adherence to Standard of Care With Durvalumab and Overcoming Barriers in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Study
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Khurram Anwar
Marshall University (US)
2 shared publications
- BPI22-024: Assessing the Adherence to Standard of Care With Durvalumab and Overcoming Barriers in the Treatment of Unresectable Stage III Non-Small Cell Lung Cancer: A Single Institution Retrospective Study
- Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era.
Said Sharawi
Marshall University (US)
2 shared publications
- Cyclic Thrombocytopenia: A Case Report
- COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura
Kelsey Marshall
Marshall University (US)
2 shared publications
- Bone Marrow Biopsy, Does CT Guidance Add Value?
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Bhavana Vemula
Edwards Comprehensive Cancer Center (US)
2 shared publications
- Bone Marrow Biopsy, Does CT Guidance Add Value?
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
Thomas W. Wright
Marshall University (US)
2 shared publications
- Role of consolidative thoracic and prophylactic cranial radiation in extensive stage small cell lung cancer in chemo-immunotherapy era.
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Yury Kachynski
2 shared publications
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Ihab Tahboub
2 shared publications
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Abraham Titus
University of South Alabama (US)
2 shared publications
- Outcome analysis of immunotherapy and possible prognostic role of pretreatment neutrophil-lymphocyte ratio in lung cancer: An Appalachian study.
- Real-World Outcomes of Immune Checkpoint Inhibitors in a Rural Appalachian Lung Cancer Cohort: Prognostic Significance of Iraes and Nlr
Hassaan Yasin
Marshall University (US)
1 shared publication
- Immunotherapy-Induced Sarcoid-Like Reaction: A Shrewd Imitator
Similar Researchers
Based on overlapping research topics
Andrew Johns
University of Central Arkansas
Cancer Immunotherapy and Biomarkers
Immune Response and Inflammation
COVID-19 Clinical Research Studies
Narenraj Arulprakash
University of Arkansas for Medical Sciences
Immune Response and Inflammation
COVID-19 Clinical Research Studies
Medical Imaging Techniques and Applications
Shae A. Merves
University of Arkansas for Medical Sciences
Immune Response and Inflammation
COVID-19 Clinical Research Studies
Medical Imaging Techniques and Applications
Shelby N. Bess
University of Arkansas at Fayetteville
Cancer Immunotherapy and Biomarkers
Immune Response and Inflammation
Medical Imaging Techniques and Applications
Timothy J. Muldoon
University of Arkansas at Fayetteville
Cancer Immunotherapy and Biomarkers
Immune Response and Inflammation
Medical Imaging Techniques and Applications
Nikhil Meena
University of Arkansas for Medical Sciences
Lung Cancer Diagnosis and Treatment
COVID-19 Clinical Research Studies
Medical Imaging Techniques and Applications